Economic Impact of Switching to Fixed-Dose Combination Therapy for Japanese Hypertensive Patients: A Retrospective Cost Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.1448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Budget Impact of a New, First-In-Class Triple Fixed Dose Combination Therapy for COPD Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cost-Minimization and Budget-Impact Analysis of Fixed-Dose Combination Inhalers in Treatment of Copd in Slovenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Disease

2014English

Cost Analysis Study of Anti-Diabetic Fixed Dose Combination Drugs: An Indian Scenario

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Fixed-Dose Combination Therapy for the Prevention of Atherosclerotic Cardiovascular Diseases

Cochrane Database of Systematic Reviews
2017English

Comparison of Therapy Persistence for Fixed Versus Free Combination Antihypertensives: A Retrospective Cohort Study

BMJ Open
Medicine
2016English

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Journal of Ophthalmology
Ophthalmology
2018English

Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2010English

Fixed-Dose Combination Therapy to Improve Hypertension Treatment and Control in Latin America

Archivos de Cardiologia de Mexico
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy